Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Offering SPR-BLI Services - Proteins provided for free! 
Get your basement membrane extract free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
Thank you for choosing ACROBiosystems. Would you rate our product and service？Thank you for choosing ACROBiosystems. Would you rate our product and service？| Cat. No. | Especies | Descripción del producto | Estructura | Pureza | Característica |
|---|---|---|---|---|---|
| AHG-Y69 | Mouse | Anti-Human IgG Antibody-Acridinium ester (MALS verified) |
|
||
| IGG-LY69 | Mouse | HRP conjugated Anti-Human-IgG-Fc Antibody (6F11C8), mAb | |||
| IGG-AY69 | Mouse | Monoclonal Anti-Human-IgG-Fc Antibody,Mouse IgG1 (6F11C8) (HPLC verified) |
|
Immobilized Human ACE2 Protein, Fc Tag (Cat. No. AC2-H5257) at 2μg/mL (100μL/well) can bind Monoclonal Anti-Human-IgG-Fc Antibody,Mouse IgG1 (6F11C8) (HPLC verified) (Cat. No. IGG-AY69) with a linear range of 0.10-3.13 ng/mL (QC tested).
The purity of Anti-Human IgG Antibody-Acridinium ester (Cat. No. AHG-Y69) is more than 90% and the molecular weight of this protein is around 140-170 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Imlifidase | Mac-1 | Approved | Hansamed Inc | Idefirix | EU | Rejection of renal transplantation | Hansa Biopharma Ab | 2020-08-25 | Rejection of renal transplantation; Purpura, Thrombotic Thrombocytopenic; Kidney Diseases; Rejection of organ transplantation; Guillain-Barre Syndrome; Renal Insufficiency, Chronic; Kidney Failure, Chronic | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Recombinant Tumor Enzyme Specific Interferon α-2b Fc Fusion (Livzon Pharmaceutical Group) | A-01 | Phase 1 Clinical | Livzon Pharmaceutical Group Inc | Solid tumours | Details |
| Anti-CD33/anti-FcgammaRI bispecific antibody (UCSD) | Phase 1 Clinical | University Of California San Diego | Leukemia, Myeloid, Acute | Details | |
| AT-02 | AT-02 | Phase 1 Clinical | Attralus Inc | Immunoglobulin Light-chain Amyloidosis; Amyloidosis | Details |
This web search service is supported by Google Inc.
A-Z
